Systematic review: Herbal medicinal products for non-ulcer dyspepsia

Alimentary Pharmacology and Therapeutics

Volumn 16, Issue 10, 2002, Pages 1689-1699

  Coon, J Thompson ^a   Ernst, E ^a  

^a UNIVERSITY OF EXETER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLASE; ATRACTYLODES EXTRACT; CASCARA; CHELIDONIUM EXTRACT; CISAPRIDE; EMBLICA OFFICINALIS EXTRACT; GINGER EXTRACT; GINSENG EXTRACT; GLYCYRRHIZIC ACID; HERBACEOUS AGENT; METOCLOPRAMIDE; NUX VOMICA; PEPPERMINT;

ANOREXIA; ARTICLE; BANANA; CARAWAY; CHELIDONIUM; CLINICAL TRIAL; CONSTIPATION; CURCUMA LONGA; DATA BASE; DIARRHEA; DRUG MECHANISM; DYSPEPSIA; EVIDENCE BASED MEDICINE; FATIGUE; HEADACHE; HERBAL MEDICINE; HUMAN; NAUSEA; PRIORITY JOURNAL; PRURITUS; SOMNOLENCE;

CARUM; DYSPEPSIA; GASTROINTESTINAL AGENTS; HUMANS; MENTHA PIPERITA; PHYTOTHERAPY; PLANT EXTRACTS; RANDOMIZED CONTROLLED TRIALS;

EID: 0036791307     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2002.01339.x     Document Type: Article

References (63)

1. Logan R, Delaney B. Implications of dyspepsia for the NHS. Br Med J 2001; 323: 675-7.
2. Johannessen T, Petersen H, Kristensen P, et al. The intensity and variability of symptoms in dyspepsia. Scand J Prim Health Care 1993; 11: 50-5.
3. Lydeard S, Jones R. Factors affecting the decision to consult with dyspepsia: comparison of consulters and non-consulters. J R Coll Gen Pract 1989; 39: 495-8.
4. Talley NJ, Zinsmeister AR, Schleck CD, et al. Dyspepsia and dyspepsia subgroups: a population based study. Gastroenterology 1992; 102: 1259-68.
5. Ernst E. Prevalence of use of complementary /alternative medicine: a systematic review. Bull WHO 2000; 78: 252-7.
6. Blumenthal M. Herb sales up 1% for all channels of trade in 2000. Herbalgram 2001; 53: 63.
7. Blumenthal M. The Complete German Commission E Monographs. Therapeutic Guide to Herbal Medicines. Austin, TX: American Botanical Council, 1988.
8. Boon H, Smith M. The Botanical Pharmacy, Ontario, Canada: Quarry Press Inc., 1999.
9. Fetrow CW, Avila JR. Professional's Handbook of Complementary and Alternative Medicines. Pennsylvania, USA: Springhouse Corporation, 1999.
10. Jadad AR, Moore A, Carroll D, et al. Assessing the quality of reports of randomised clinical trials: is blinding necessary? Control Clin Trials 1996; 17: 1-12.
11. Arora A, Sharma MP. Use of banana in non-ulcer dyspepsia. Lancet 1990; 335: 612-3.
12. Chawla YK, Dubey P, Singh R, et al. Treatment of dyspepsia with Amalaki (Emblica officinalis Linn.) - an Ayurvedic drug. Indian J Med Res 1982; 76: 95-8.
13. Tatsuta M, Iishi H. Effect of treatment with Liu-Jun-Zi-Tang (TJ-43) on gastric emptying and gastrointestinal symptoms in dyspeptic patients. Aliment Pharmacol Ther 1993; 7: 459-62.
14. May B, Kohler S, Schneider B, Efficacy and tolerability of a fixed combination of peppermint oil and caraway oil in patients suffering from functional dyspepsia. Aliment Pharmacol Ther 2000; 14: 1671-7.
15. May B, Kuntz H-D, Kieser M, et al. Efficacy of a fixed peppermint oil/caraway oil combination in non-ulcer dyspepsia. Arzneimittelforschung 1996; 46: 1149-53.
16. Freise J, Kohler S. Peppermint oil/caraway oil fixed combination in non-ulcer dyspepsia. Equivalent efficacy of the drug combination in an enteric coated or enteric soluble formulation. Pharmazie 1999; 54: 210-5.
17. Madisch A, Heydenreich CJ, Wieland V, et al. Treatment of functional dyspepsia with a fixed peppermint oil and caraway oil combination preparation as compared to cisapride. Arzneimittelforschung 1999; 49: 925-32.
18. Madisch A, Melderis H, Mayr G, et al. Commercially available herbal preparation and its modified dispense in patients with functional dyspepsia. Results of a double blind, placebo controlled, randomised multicentre trial. Z Gastroenterol 2001; 39: 511-7.
19. Nicolay K. Funktionelle Gastroenteropathien im therapeutischen Blindvergleich von Metoclopramid mit dem Phytopharmakon Iberogast. Gastro-Entero-Hepatologie 1984; 2: 1-12.
20. Westphal J, Horning M. Leonhardt K. Phytotherapy in functional upper abdominal complaints. Results of a clinical study with a preparation of several plants. Phytomedicine 1996; 2: 285-91.
21. Stadelmann O, Kohler S, Kieser M, et al. Pfefferminzol/Ingwerextrakt bei funktioneller Dyspepsie. Randomisierte plazebokontrollierte Wirksamkeits und Vertraglichkeitsstudie mit Kombinationspraparat. Leber Magen Darm 1999; 29: 1-8.
22. Ritter R, Schatton WFH, Gessner B, et al. Clinical trial on standardised celandine extract in patients with functional epigastric complaints: results of a placebo controlled double blind trial. Complement Ther Med 1993; 1: 189-93.
23. Thamlikitkul V, Dechatiwongse T, Chantrakul C, et al. Randomised double blind study of Curcuma domestica Val. for dyspepsia. J Med Assoc Thai 1989; 72: 613-20.
24. Chen Z. Clinical and experimental study on non-ulceratic dyspepsia treated with shenxia hewining. Zhong Xi Yi Jie He Za Zhi 1994; 14: 83-5.
25. Holtmann G, Madisch A, Hotz J, et al. A double blind, randomised, placebo-controlled trial on the effects of a herbal preparation in patients with functional dyspepsia. Gastroenterology 1999; 116: A65(Abstract).
26. Rosch W. Phytotherapie bei der funktionellen Dyspepsie. Eine vergleichende Studie Cisapride vs Iberogast bei der Dyspepsie vom Dysmotilitatstyp. Med Klin 2001; 96: 189, P272.
27. Borgia M, Camarri E, Cataldi V, et al. Studio policentrico doppio-cieco doppio-controllato sull'attivita terapeutica di una nota associazione di erbe medicamentose. Clin Ter 1985; 114: 401-9.
28. Brinker F. Botanical review. Chelidonium majus. J Naturopath Med 1992; 3: 93-4.
29. Chang HM, But PPH. Pharmacology and Applications of Chinese Materia Medica. Singapore: World Scientific Publishing, 1987.
30. Lewis DA, Fields WN, Shaw GP, A natural flavonoid present in unripe banana pulp (Musa sapientum L var paradisiaca) protects the gastric mucosa from aspirin-induced erosions. J Ethnopharmacol 1999; 65: 283-8.
31. Tatsuta M, Iishi H, Okuda S. Gastric emptying and gastrointestinal symptoms in patients with atrophic gastritis and the effects of domperidone. Scand J Gastroenterol 1989; 24: 251-6.
32. Naito T, Itoh H, Yasunga F, et al. Rikkunshi-to raises levels of somatostatin and gastrin in human plasma. Biol Pharm Bull 2001; 24: 841-3.
33. Hayakawa T, Arakawa K, Kase Y, et al. Liu-Jun-Zi-Tang, a kampo medicine, promotes adaptive relaxation in isolated guinea pig stomachs. Drugs Exp Clin Res 1999; 25: 211-8.
34. Lawrence BM. Progress in essential oils: Peppermint oil. Perfum Flavor 1993; 18: 59-72.
35. Hills JM, Aaronson PI. The mechanism of action of peppermint oil on gastrointestinal smooth muscle. An analysis using patch clamp electrophysiology and isolated tissue pharmacology in rabbit and guinea pig. Gastroenterology 1991; 101: 55-65.
36. Hawthorne M, Ferrante J, Luchowski E, et al. Menthol and peppermint oil actions on calcium channel dependent processes in cardiac, intestinal and neuronal preparations. Aliment Pharmacol Ther 1988; 2: 101-18.
37. Forster HB, Niklas H, Lutz S. Antispasmodic effects of some medicinal plants. Planta Med 1980; 40: 309-19.
38. Bruneton J. Pharmacognosy, Phytochemisry, Medicinal Plants. Paris: Lavoisier Publishing, 1999.
39. Speisky H, Cassels BK. Boldo and boldine: an emerging case of natural drug development. Pharm Res 1994; 29: 1-12.
40. Kniebel R, Urlacher W. Therapie krampfartiger Abdominal-schmerzen. Z Allg Med 1993; 69: 680-4.
41. Benninger J, Schneider HT, Schuppan D, et al. Acute hepatitis induced by greater Celandine (Chelidonium majus). Gastroenterology 1999; 117: 1234-7.
42. Greving I, Meister V, Monnerjahn C, et al. Chelidonium majus: a rare reason for severe hepatotoxic reaction. Pharmacoepidemiol Drug Safety 1998; 7: S66-9.
43. Etxenagusia MA, Anda M, Gonzalez-Mahave I, et al. Contact dermatitis from Chelidonium majus (greater celandine). Contact Dermatitis 2000; 43: 47.
44. Maruyama Y, Maruyama M, Takada T, et al. A case of pneumonitis due to Rikkunshi-to. Nihon Kyobu Shikkan Gakkai Zasshi 1994; 32: 84-9.
45. Sassin I. Buchert D. Efficacy and tolerability of the herbal preparation Iberogast in the therapy of functional dyspepsia. Phytomedicine 2000: 7(Suppl. II): 91-2.
46. Andersen KE. Contact allergy to toothpaste flavours. Contact Dermatitis 1978; 4: 195-8.
47. Calnan CD. Oil of cloves, laurel, lavender, peppermint. Contact Dermatitis Newsletter 1970; 7: 148.
48. Wilkinson SM, Beck MH. Allergic contact dermatitis from menthol in peppermint. Contact Dermatitis 1994; 30: 42-3.
49. McGowan EM. Menthol urticaria. Arch Dermatol 1966; 94: 62-3.
50. Parys BT. Chemical burns resulting from contact with peppermint oil mar: a case report. Burns Incl Therm Inj 1983; 9: 374-5.
51. Weston CFM. Anal burning and peppermint oil. Postgrad Med J 1987; 63: 717.
52. Spurlock BW. Dailey TM, Shortness of (fresh) breath - toothpaste induced bronchospasm. N Engl J Med 1990; 323: 1845-6.
53. Thomas JG. Peppermint fibrillation. Lancet 1962; i: 222.
54. Mearin F, Balboa A, Zarate N, et al. Placebo in functional dyspepsia: symptomatic, gastrointestinal motor and gastric sensorial responses. Am J Gastroenterol 1999; 94: 116-25.
55. Veldhuyzen van Zanten SJO, Cleary C, Talley NJ, et al. Drug treatment of functional dyspepsia: a systematic analysis of trial methodology with recommendations for design of future trials. Am J Gastroenterol 1996; 91: 628-9.
56. Nyren O, Adami H-O, Bates S, et al. Absence of therapeutic benefit from antacids or cimetidine in non-ulcer dyspepsia. N Engl J Med 1986; 314: 339-43.
57. Dobrilla G, Comberlato M, Steele A, et al. Drug treatment of functional dyspepsia - a meta-analysis of randomised controlled clinical trials. J Clin Gastroenterol 1989; 11: 169-77.
58. Moayyedi P, Soo S, Deeks J, et al. Systematic review and economic evaluation of Helicobacter pylori eradication therapy for non-ulcer dyspepsia. Br Med J 2000; 321: 659-64.
59. Williamson EM. Synergy and other interactions in phytomedicines. Phytomedicine 2001; 8: 401-9.
60. Ernst E, De Smet PAGM, Shaw D, et al. Traditional remedies and the 'test of time'. Eur J Clin Pharmacol 1998; 54: 99-100.
61. Ernst E. Interactions between synthetic and herbal medicinal products. Part 2: a systematic review of the direct evidence. Perfusion 2000; 13: 60-70.
62. Ernst E. Possible interactions between synthetic and herbal medicinal products. Part 1: a systematic review of the indirect evidence. Perfusion 2000; 13: 4-15.
63. Fugh-Berman A. Herb-drug interactions. Lancet 2000; 355: 134-8.